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The ionized calcium level in blood is known to be falsely
decreased when self-prepared liquid heparin anticoagulant is
used, due to dilution and binding effects. The effect of liquid
heparin on the determination of ionized magnesium is not as
well understood. We compared the effect of liquid sodium
heparin on the determination of ionized calcium and magne-
sium in 44 clinical samples using two types of user-prepared
heparin syringes which differed in the amount of residual
heparin from the BD Preset
TM reference syringe. With the
type 1 syringe, the liquid heparin was expelled once or twice
such that some heparin could be left in the dead space at the
syringe hub, while the liquid sodium heparin was thoroughly
expelled from the type 2 syringe. The ionized magnesium lev-
els obtained with the type 1 syringe were significantly lower
than the reference value (by 0.068 mmol/L) (p < 0.0001),
while the value obtained with the type 2 syringe differed less
from the reference, by only 0.014 mmol/L (p < 0.0001). The
heparin binding effect resulted in more negative bias in
ionized magnesium (- 0.026 ± 0.032 mmol/L) than in ionized
calcium (- 0.009 ± 0.042 mmol/L, p < 0.0001). In conclu-
sion, we recommend using lyophilized, calcium-balanced,
heparinized syringes for the determination of ionized magne-
sium and ionized calcium due to the increased negative bias
in ionized magnesium determinations. When user-prepared
syringes are used, the thorough evacuation of heparin solution
should be strictly prescribed.
Key Words: Calcium, heparin, ion, magnesium
INTRODUCTION
The ionized calcium level in blood is known to
be falsely decreased due to dilution and binding
effects when self-prepared liquid heparin anticoa-
gulants are used.
1 The CSLI (Clinical and Labora-
tory Standard Institute, formerly the National
Committee for Clinical Laboratory Standards or
NCCLS) recommends the use of lyophilized
calcium-balanced heparin syringes
2 for collecting
specimens for ionized calcium measurement.
Although excess heparin has been suggested to
affect ionized calcium levels,
3 such an effect on the
measurement of ionized magnesium has not been
documented. Some commercial calcium-balanced
heparin syringes have been reported to affect
ionized magnesium levels, although the clinical
significance was believed to be minimal.
4 Liquid
heparin may still be used for the determination of
ionized calcium or magnesium by some clinical
laboratories in developing countries due to bud-
getary constraints. In this study, we set out to
systematically determine the liquid heparin effect
on both ionized calcium and magnesium in clini-
cal samples by head-to-head comparison.
MATERIALS AND METHODS
Samples were obtained from the 44 patients to
evaluate the effect of heparin on ionized magne-
sium levels. Informed consent was obtained from
the patients and the study protocol was approved
by the institutional review board.
We made user-prepared syringes using sodium
heparin, 1000 U/mL (Choongwae Pharma Corpo-
ration, Seoul, Korea), which concentration was
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specially manufactured to reduce the heparin
concentration for blood sampling and was lower
than the common value prescribed for therapeutic
heparinization. Heparin in the amount of 0.5 to
1.0 mL was drawn into a 2-mL syringe to coat the
whole inner surface of the syringe, and was then
expelled back into the original vial. Before and
after coating the inner surface of the blood gas
syringe with heparin, we tared the syringe on the
electronic balance to calculate the amount of
heparin solution remaining in the syringe after
expulsion. The needle was then changed to one
appropriate for collecting the sample. Two types
of syringes which differed in their heparin coating
protocols were compared to the reference syringe
(lyophilized calcium balanced lithium heparin, BD
Preset
TM syringe, 30 I.U., BD, Franklin Lakes, NJ,
USA) according to the behavioral pattern of the
users as follows. With the type 1 syringe, heparin
and air was ejected once or twice such that
heparin may have been left in the dead space of
syringe hub. In contrast, heparin and air were
ejected methodically several times from the type
2 syringe until heparin was not detectable in
either the syringe or the needle. Although bias
may remain for the calcium balanced lithium
heparin syringe compared to whole blood without
anticoagulation,
4 we used it as the reference.
Drawing 1.5 ml of whole arterial blood from each
subject into each syringe, the samples were then
recapped until analysis. Ionized calcium and mag-
nesium were measured in all samples within 20
minutes after collection using Stat Profile M
(Nova Biomedical, Waltham, MA, USA). The 'bias
corrected by dilution effect' was calculated by
subtracting the expected ion concentration from
the actual value. The expected ion concentration
was calculated as the ion concentration of the ref-
erence syringe multiplied by the following factor.
Factor = 1.5/(1.5 + V)
where '1.5' is the volume (mL) of whole blood
drawn from the patient and 'V' is the volume
(mL) of the liquid heparin remaining in the
syringe.
We analyzed the agreement of the three kinds
of blood gas syringes for both ionized calcium
and magnesium by Passing and Bablok analysis,
linear regression analysis, and Pearson correlation
using Analyse-it software (Leeds, England, UK).
The bias of type 1 or 2 syringes was calculated
against the calcium balanced lithium reference.
RESULTS
Table 1 shows that traces of heparin were found
in user-prepared syringes, with type 2 syringes
containing much less heparin than type 1.
The type 1 syringe showed significant negative
bias in both ionized calcium and magnesium
levels (Table 2). However, the type 2 syringe,
which contained less heparin, showed different
results between the two tests; there was a sta-
tistically significant negative mean bias (- 0.007
mmol/L) for ionized magnesium, but no signi-
ficant mean bias (0.006 mmol/L) for ionized cal-
cium (Table 2). The user-prepared heparinized
syringes exhibited more than 10% negative bias
above the level of 40 U/ml of heparin for ionized
calcium (Fig. 1A), and above the level of 14 U/ml
of heparin for ionized magnesium (Fig. 1B) with
the user-prepared heparinized syringes. Table 3
shows that significant negative bias of the ionized
magnesium compared to the ionized calcium
could be observed if the dilution effect was
excluded.
Table 1. The Mean Volume and Concentration of Heparin Remaining in a Blood Gas Syringe after Blood Drawing
According to Syringe Type
Variable Type 1* syringe Type 2 syringe p value
Residual volume of heparin ( L) μ 75.5 ± 25.7 21.0 ± 6.7 < 0.0001
Final heparin concentration (U/mL) 47.7 ± 15.6 13.8 ± 4.3 < 0.0001
*Type 1 syringe: heparin and air ejected once or twice such that the heparin could remain in the dead space of the syringe hub.
Type 2 syringe: heparin and air ejected carefully several times until no heparin was observed in either the syringe or the needle.
Volume of heparin solution that remained in syringes ( L). μHeparin on the Determination of Ionized Mg
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Table 2. The Bias of Ionized Calcium and Ionized Magnesium Values Measured in Type 1 or Type 2 User-Prepared
Syringes Compared to a Reference Type 3 Syringe Containing Calcium Balanced Lithium Heparin
Test item Bias Mean Bias (mmol/L) Range of Bias (mmol/L) *p value
Ionized
calcium
Type 1 syringe 0.079 (- 0.098 to - 0.060) - 0.25 to 0.05 < 0.0001
Type 2 syringe - 0.010 (- 0.016 to - 0.004) - 0.08 to 0.03 < 0.005
Corrected bias of
type 2 syringe
0.006 (0.000 to 0.012) - 0.06 to 0.05 NS
Ionized
magnesium
Type 1 syringe - 0.068 (- 0.079 to - 0.056) - 0.17 to 0.00 < 0.0001
Type 2 syringe - 0.014 (- 0.020 to - 0.009) - 0.05 to 0.02 < 0.0001
Corrected bias of
type 2 syringe
- 0.007 (- 0.012 to - 0.002) - 0.04 to 0.02 < 0.01
Type 1 and Type 2 syringes were previously described in Table 1.
*p values were derived from a paired t-test between the observed and reference syringe (the commercially available blood gas
‘BD Preset
TM syringe’).
Corrected bias for the dilution effect is described in the text, which represents only the heparin binding effect. The numbers
in parentheses are the mean bias at the 95% confidence interval.
NS, ‘not significant’ (p > 0.05)
Fig. 1. The percent bias of ionized calcium or ionized magnesium according to the final heparin concentration in a
user-prepared syringe. A: percent bias of ionized calcium. B: percent bias of ionized magnesium. C: percent bias of ionized
calcium excluding the dilution effect. D: percent bias of ionized magnesium excluding the dilution effect.
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DISCUSSION
As the ionized fraction of magnesium is the
biologically active part, its accurate determination
is an important issue in critically ill patients.
5,6 The
CLSI recommends that whole blood determi-
nations of ionized calcium be performed on speci-
mens transferred into commercially available,
ready-to-use syringes or capillaries anticoagulated
with one of the modified preparations of heparin
designed to minimize its effects on the ionized
calcium.
3 However, the performance of these
syringes with ionized magnesium has not been
documented. We found a clear reduction in mea-
sured ionized magnesium levels with increasing
concentrations of heparin in syringes, confirming
previous reports.
2,7 We postulate that ionized
magnesium measurements are more greatly im-
pacted by liquid heparin than ionized calcium
values, as the absolute amount of ionized magne-
sium is much less than that of ionized calcium.
We did not, however, confirm its mechanism. The
maximum allowable heparin concentration in
syringes was proposed to be 40 U/mL or 15 U/mL
for ionized magnesium.
7,8 For ionized calcium, the
CLSI recommends that the calcium balanced
heparin concentration should be 70 U/mL or less.
We found a greater than 10% negative bias above
the clinical prescribed level of 40 U/mL of heparin
for ionized calcium, and above the level of 14 U/
mL of heparin for ionized magnesium in user-
prepared heparinized syringes, due to both dilu-
tion and heparin binding effects. If the liquid
heparin was deliberately and thoroughly expelled
from the blood gas syringe, the mean bias in
values did not exceed - 0.08 mmol/L for ionized
calcium and - 0.05 mmol/L for ionized magne-
sium, putting the values within a clinically accept-
able range.
Although Chantler and Cox showed that self-
prepared heparinized syringes for measuring
ionized magnesium and calcium were sufficiently
close to dry balanced heparinized syringes to
justify their use under economically constraining
conditions,
9 the protocol of thoroughly expelling
the heparin solution should be mandated to mini-
mize dilution and heparin binding effects.
In conclusion, we recommend using lyophilized
calcium balanced heparinized syringes for the
determination of ionized magnesium as well as
ionized calcium, as we observed a greater nega-
tive bias of ionized magnesium values compared
with ionized calcium in the presence of residual
heparin. In the case of using user-prepared
syringes, a protocol for thorough evacuation of
heparin solution should be standardized and
mandated.
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